Canadian application, no grantCanada
Immune mediators and related methods
CA 2403432 A1 · Owner: Wang, Aijun · Inventors: Zhu, Shirley; Wang, Aijun; Carter, Darrick
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to nucleic acids encoding single chain MHC class II molecules that form multimers via inter-chain multimerization domains and , methods of treating autoimmune disease using the same.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 22, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 22, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 22, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMarch 22, 2001
GrantedNo grant recorded
Term endedMarch 22, 2021
Patent numberCA 2403432 A1
Classification (IPC)A61K35/28 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.